How to Implement an AI Receptionist in a Pharmacy

An AI receptionist should not go from a sales demo to every pharmacy call overnight. A controlled rollout starts with evidence, limits, and a way back.

This guide covers the work between choosing a system and trusting it with live calls. It focuses on operating decisions, not provider comparisons or product features.

If you are still selecting a system, start with the pharmacy AI receptionist buyer scorecard.

This article is general information, not legal or clinical advice. Check your obligations and obtain advice for your pharmacy, systems, and jurisdiction.

Before implementation: which Australian guidance applies?

Several Australian frameworks provide a sound rollout model, although they do not all govern community pharmacies directly.

The Digital Transformation Agency proof-of-concept guidance is written for government. The National AI Centre also publishes six essential practices for complex or higher-risk AI use.

This article applies their testing and governance principles to an administrative phone workflow. It treats the guidance as a practical model, not as pharmacy law.

Step 1: Record the baseline before changing the phone

A pilot needs a comparison point. Otherwise, a quieter week or enthusiastic staff feedback can look like proof that the system worked.

The Australian Government’s proof-of-concept guidance calls for defined success metrics, baselines, and systematic evaluation. That principle transfers cleanly to a pharmacy phone pilot.

Pull a representative period of call-detail records before configuration. The method in our phone audit guide uses inbound timestamps, duration, disposition, and trading hours.

Add a manual sample of call reasons. Phone logs show whether someone answered, but not whether the caller’s request was resolved correctly.

Measure	Baseline evidence	Pilot evidence
Calls answered	Phone-system disposition	Agent and phone-system logs agree
Waiting and abandonment	Ring duration before pickup or disconnect	Time to answer and caller disconnects
Routine requests resolved	Staff review of a call sample	Reviewed outcomes from the same request types
Clinical escalation	Current staff handling path	Correct transfer or structured callback
Follow-up work completed	Existing notes or task records	Tickets created, assigned, and closed
Human requests honoured	Current transfer experience	Transfer result and fallback outcome
Complaints and near misses	Existing incident or complaint records	One combined pilot log

Write down the business problem in one sentence. Then connect each measure to that problem. A metric without a decision attached becomes dashboard decoration.

Step 2: Define allowed tasks and clinical boundaries

Start with an allowed-task list, not a catalogue of everything the technology could attempt.

Routine administrative tasks may include opening hours, service information, collection status, delivery requests, and structured callback messages. Access to patient-specific information needs suitable identity controls.

The prohibited list matters more. The agent should not interpret symptoms, recommend treatment, advise on doses, assess interactions, or decide whether medicine use is safe.

Software may be regulated as a medical device when its intended purpose helps diagnose, monitor, or treat health conditions. That is a regulatory boundary, not a complete product classification.

Use it as a hard design signal. When a caller moves from logistics into clinical advice, the workflow should move to a pharmacist.

Build a risk register around real failures

Current Australian Government AI implementation guidance calls for a documented risk framework, use-case assessment, treatment plans, and clear acceptance criteria.

Keep the first register practical enough to use during test calls.

Failure	Possible harm	Required control	Evidence before go-live
Clinical question receives an answer	Inappropriate advice	Clinical-intent handoff	Test record shows the transfer path
Wrong patient is matched	Health information disclosed	Identity check and safe refusal	Negative identity tests pass
Source data is stale or unavailable	Incorrect status given	Timestamp check and fail-safe response	Forced outage test passes
Ticket is not actioned	Patient request is lost	Named queue owner and alerts	End-to-end ticket test closes
Caller asks for a person	Caller becomes trapped	Immediate human route or callback	Handoff test completes
Phone or integration fails	Calls cannot be handled safely	Tested diversion or message path	Fallback drill completes

Include foreseeable misuse. A caller may press for a medicine recommendation, provide another person’s details, or disguise an urgent clinical question as a status request.

Step 3: Map data, privacy, and system access

Do not use live patient calls to discover how the product handles data.

The OAIC recommends privacy by design and a Privacy Impact Assessment. Its guidance also calls for product testing, human oversight, data-flow review, staff training, and lifecycle monitoring.

Before the pilot, the pharmacy and provider should document:

• what audio, transcripts, identifiers, prompts, outputs, and tickets are created
• where each item is processed and stored
• who can access it, including subcontractors
• whether any data is used to train or improve models
• the retention period and verified deletion process
• the minimum dispense-system permissions needed
• how callers are told they are speaking with AI
• how access, changes, and incidents are logged

Use the dispense-software integration guide for permissions, source-of-truth rules, stale data, and reconciliation tests.

APP 11 requires reasonable technical and organisational safeguards. It also requires information to be destroyed or de-identified when it is no longer needed, subject to lawful retention requirements.

The OAIC’s APP 11 guidance confirms that outsourced information can remain under the pharmacy’s control. A vendor contract does not remove that responsibility.

Our pharmacy AI privacy guide covers the legal context in more detail. The rollout document only needs the approved decisions and evidence.

Step 4: Test routine, safety, and failure scenarios

A polished demo proves that one prepared conversation worked. Implementation testing asks what happens across normal calls, awkward calls, and broken systems.

The current guidance calls for clear acceptance criteria, pre-deployment testing, documented outcomes, and additional evaluation proportionate to risk.

Build a scenario pack from your own call sample. Use fictional patient data until privacy and access controls are approved.

Routine scenarios

• ordinary opening-hours and service questions
• a collection-status request with the expected identity checks
• a delivery request that becomes an assigned ticket
• a public-holiday or temporarily changed opening time
• a caller who changes their request halfway through

Safety and control scenarios

• symptoms, dose, interaction, substitution, and side-effect questions
• a distressed caller or language suggesting urgency
• an explicit request for a pharmacist or another person
• repeated misunderstanding or conflicting caller details
• an attempt to obtain another person’s information

Speech and operating scenarios

• background noise, an unfamiliar medicine name, varied speaking pace, and different accents
• two requests in one call
• overlapping calls during a busy period
• dispense data that is missing, stale, or contradictory
• loss of the dispense connection, phone connection, or ticket destination

For each scenario, record the expected outcome, observed outcome, evidence, owner, and retest result. “Sounded good” is not an acceptance criterion.

The AI Clinical Use Guide warns that evidence from controlled settings may not represent real workflows. It also calls for ongoing review of scope and performance.

That guide addresses clinical AI. Here, its value is defining what the administrative system must escalate and what a pharmacist must continue to own.

Step 5: Design the fallback before the failure

A fallback is not “call support.” It is the exact caller and staff experience when a dependency stops working.

Event	Immediate safe state	Staff action
Voice service unavailable	Divert calls to the tested manual route	Confirm diversion and notify the provider
Dispense connection unavailable	Give no patient-specific status	Transfer or create a verified callback
Staff transfer unavailable	State the callback process clearly	Assign and monitor the callback queue
Ticket destination unavailable	Store no untracked promise	Route to the approved alternative queue
Suspected privacy incident	Restrict access and preserve records	Activate the incident response plan

ASD’s incident response guidance says plans should align with business continuity arrangements. It also recommends clear roles, tested exercises, and backup communications.

Run the fallback as a drill. Confirm staff can disable or divert the system without relying on the same failed service.

Prepare the incident card

Keep a short incident card where staff can find it quickly. It should name who contains the issue, contacts the provider, reviews logs, assesses privacy risk, and approves restoration.

The OAIC’s data breach response guidance calls for written roles, escalation lines, records, external contacts, testing, and post-incident review.

For a suspected eligible breach, entities must take reasonable steps to complete the assessment within 30 calendar days. The OAIC treats that as a maximum, not a waiting period.

Operational containment should begin immediately. The response pattern is contain, assess, notify when required, then review.

Step 6: Give every part of the workflow an owner

The pharmacy remains accountable for how the system operates. A provider can support monitoring and maintenance, but cannot own the pharmacy’s clinical judgement.

The Australian Digital Health Agency’s framework uses five clinical governance principles. They cover leadership, evidence, partnership, person-centredness, and system safety with continuous improvement.

A small pharmacy does not need a large committee. It does need named people with authority to act.

Role	Owns
Pharmacy owner or manager	Pilot outcome, risk acceptance, and deployment approval
Pharmacist lead	Clinical boundary, escalation rules, and safety review
Operations lead	Call content, ticket queue, completion, and staff feedback
Privacy or security contact	Data decisions, access, incidents, and required notifications
Provider contact	Technical faults, changes, logs, and agreed service response

Train every staff member on the allowed scope, handoff, ticket queue, incident reporting, and manual fallback. Then ask them to demonstrate those actions.

Give staff one place to report a wrong answer, failed transfer, missing ticket, privacy concern, or caller complaint. Reports need an owner and a visible outcome.

Step 7: Pilot narrowly, monitor, then decide

Start with a controlled routing mode and a defined call window. Keep the manual path available while the team collects evidence against the acceptance criteria.

Review outcome measures, not just call volume. A high answer rate means little if requests are incorrect, transfers fail, or follow-up work remains untouched.

Monitor:

• correct resolution by approved request type
• clinical, complex, and human-request escalation outcomes
• identity-check failures and safe refusals
• ticket creation, assignment, ageing, and completion
• integration errors, fallback events, and recovery
• caller complaints, staff reports, near misses, and incidents
• changes after configuration, integration, or model updates

Compare pilot results with the baseline using the same definitions. Re-test any failed scenario after changes, and repeat relevant tests when the system or workflow changes.

The go-live gate

Do not expand the system because the trial period ended. Expand it when the evidence supports the decision.

• The local baseline and intended outcome are documented.
• Allowed tasks and prohibited clinical actions are approved.
• Every safety-critical scenario meets its acceptance criterion.
• Privacy, access, retention, and caller-notice actions are complete.
• Tickets have owners and can be tracked to closure.
• Staff can transfer, intervene, report an issue, and activate fallback.
• The incident plan and independent communication path have been tested.
• Monitoring, feedback, logs, and review ownership are active.
• Material limitations and unresolved lower-risk issues are recorded.
• The pharmacy owner and pharmacist lead approve wider deployment.

If a safety-critical item is not ready, keep the pilot narrow. Fixing a known gap before expansion is part of implementation, not a failed launch.

Where Krepko fits

Implementation starts with Kat’s pilot boundary: administrative call management for an agreed pharmacy workflow. Kat owns the scoped calls, requests, consent and identity steps, context, ticketing, summaries, assignment and follow-up.

Any dispense-software, phone, email or SMS connection needs separate agreement on compatibility, permissions and third-party systems. Before configuration, document the pilot’s call scope, staff owner, escalation path and follow-up process. Send clinical, complex, uncertain or human-requested calls to pharmacy staff, who retain professional decision authority.

Our published beta provides useful operational clues, but not a national benchmark. It covered one pharmacy, 195 calls, and 46.8 active hours.

In that limited beta, 57 percent of handled calls produced an actionable ticket, and staff completed 84.8 percent of those tickets. The method and limitations are published here.

Those figures reinforce the implementation lesson. Measure whether the handoff produces completed work, then judge the system against your pharmacy’s own baseline and risk controls.

Map the implementation plan to an agreed scope when you book a Krepko demo.